Sorority rush gets Ozempic makeover as some college women resort to weight-loss injections
Rising Use of Weight‑Loss Drugs Among College Students Sparks Concern
Portland, Me. — A rapid surge in prescriptions for GLP‑1 medications is now extending beyond traditional adult users to younger adults, especially women attending college. Recent data and campus anecdotes paint a picture of a growing phenomenon that is drawing both medical warnings and cultural scrutiny.
The Numbers Behind the Trend
A 2024 analysis published in the Journal of the American Medical Association counted more than 162,000 individuals aged 18 to 25 who received at least one filled prescription for a GLP‑1 drug in 2023. Roughly three‑quarters of those patients were female, a disparity that mirrors broader usage patterns for medications such as semaglutide (marketed as Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound). The trend is not limited to older adults; market research indicates that adults under 40, and particularly young women, are now the fastest‑growing segment of GLP‑1 users.
A separate survey, the 2025 Monitoring the Future study, found that about 2 % of high‑school students in grades 8, 10 and 12 reported using a prescription GLP‑1 medication, while an additional 2 % said they had obtained the drugs without a prescription. Those figures suggest that the practice is beginning to take root even before many students reach university age.
Campus Culture and the “Ozempic” Effect
Campus journalists and health experts have started to notice a shift in social dynamics on several elite campuses. A feature in The Cut titled “The Secret ‘Ozempic’ Epidemic on Sorority Row” described how weight‑loss injections have become an informal part of recruitment rituals. Several students, speaking anonymously, said they turned to compounded versions of semaglutide or tirzepatide to improve their appearance during rush week and to meet what they described as an increasingly thin beauty standard.
One student explained that arriving at college felt like a race to be seen as thin, noting that “the pressure to look extremely thin” was amplified by social media and competitions among friends. Another recalled thinking, “I didn’t realize that someone who was 19 and also not super‑overweight could get on it. I was like, ‘I gotta hop on.’” A former sorority recruiter added that the attitude was, “There’s just no excuse for people to be fat because they could just get a GLP‑1.”
Expert Warnings About Risks and Misuse
Jay Campbell, a longevity and peptide specialist who has written bestselling books on health, cautioned that the drugs, while effective for genuine metabolic conditions, are being “hijacked as a cosmetic shortcut.” He described how a medication designed for people with metabolic dysregulation can look like “an aesthetic hack in a syringe” to a 20‑year‑old with a normal body‑mass index.
Campbell warned that rapid weight loss without adequate protein intake and resistance training can lead to a disproportionate loss of lean muscle mass, a concern compounded by the phenomenon sometimes called “Ozempic face” or “Ozempic body.” He emphasized that a healthy young adult has less metabolic reserve to lose, making muscle depletion more likely. He urged anyone considering the medication to ask themselves, “If you’re not obese or metabolically compromised, why are you taking a drug meant for a disease you don’t have?”
The expert also highlighted fertility considerations. GLP‑1 drugs are contraindicated during pregnancy, and labeling for semaglutide advises stopping treatment at least two months before a planned conception. For those on tirzepatide, the FDA warns that the medication can diminish the effectiveness of oral hormonal contraceptives, recommending an alternative birth‑control method for four weeks during dose initiation or escalation.
Mental health professionals note that young adults already prone to body‑image concerns may find the drugs exacerbate disordered eating patterns. While regulatory agencies have not found a direct link between GLP‑1 use and suicidal thoughts, patients are advised to report any new or worsening mood symptoms to their prescriber.
What Students Should Consider Before Starting Treatment
Campbell outlined a series of steps for anyone contemplating GLP‑1 therapy for weight loss:
- Medical Evaluation – Ensure a qualified prescriber reviews the patient’s full medical history, current medications and overall health goals.
- ** honest Motivation** – Reflect on whether the desire to lose weight stems from a legitimate health need or social pressure.
- Nutrition and Exercise Plan – Commit to sufficient protein intake and regular resistance training to protect muscle mass.
- Monitoring – Schedule regular follow‑ups to track weight loss, side effects and any changes in mood, menstrual cycles or fertility plans.
- Alternative Strategies – Explore behavioral interventions, counseling or other non‑pharmacologic approaches before relying on medication.
The Bigger Picture
The rise of GLP‑1 use among college students reflects a broader cultural shift toward quick‑fix solutions for body image. As one commentator noted, “We’ve built a pharmaceutical shortcut that used to require months of behavior change, and young women in high‑visibility social environments are early adopters of anything that changes how they look, fast.”
While the medications can be life‑changing for people with obesity or diabetes, the long‑term consequences for young adults who start with normal weight remain largely unknown. Clinical trials have not extensively studied decades‑long use in this demographic, and experts caution against treating powerful metabolic drugs as lifestyle accessories.
Calls for Comment
Fox News Digital requested comment from the National Panhellenic Conference and from the manufacturers of the GLP‑1 drugs. No response was received at the time of publication.
The story underscores the need for comprehensive education, careful medical oversight and a deeper conversation about the social pressures that drive young adults to turn to prescription weight‑loss medication. As the trend continues to evolve, health professionals and campus leaders are urging a balanced approach that prioritizes safety alongside the desire for rapid transformation.